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ABSTRACT
The greater saphenous vein (GSV) remains the most com-
monly harvested conduit for revascularization in coronary
artery bypass grafting (CABG). Published literature shows
that minimally invasive vein harvesting techniques have a
significantly lower incidence of wound infection rates
than conventional open vein harvesting techniques have.
We report a case of necrotizing fasciitis, an infection with
a mortality rate of 30% to 50%, after endoscopic harvesting
of the greater saphenous vein to be used as a conduit in a
CABG procedure. Though minimally invasive vein har-
vesting techniques have advantages of smaller incisions
and a decreased overall rate of wound infection, clinicians
should be aware of this potentially lethal infection that
may occur.
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INTRODUCTION
Coronary artery bypass grafting (CABG) is the most com-
mon operation in cardiac surgery. The greater saphenous
vein (GSV) remains the most commonly harvested conduit
for revascularization in CABG surgery. Multiple studies in
the literature have examined lower extremity infection
rates after vein harvesting. Studies show a clear advantage
of minimally invasive vein harvesting (MIVH) techniques
with harvest surgical site infection of 3% to 13%1,2 com-
pared to 12% to 29%, and even as high as 43.8% with
conventional vein harvests (CVH).3,4 Though technically
more difficult and time consuming, MIVH has been en-
dorsed by many over CVH. We reviewed 19 randomized
controlled trials that compared the incidence of leg
wound infection after minimally invasive and open saphe-
nous vein harvesting,5–23 (Table 1) where almost all stud-
ies showed the superiority of the endoscopic technique
over the open one and its almost absolute safety.
Necrotizing fasciitis is a rare but serious and often lethal
infection of the soft tissue, characterized by rapid and
progressive necrosis of subcutaneous fat, superficial fascia
with relative sparing of skin and underlying muscles.
Smoking, diabetes, intravenous drug use, peripheral vas-
cular occlusive disease, and consuming diseases are pre-
disposing factors, but the disease can also develop in
otherwise healthy patients. Necrotizing fasciitis can occur
after surgical procedures, minor trauma, trivial scratches,
or even in apparently intact skin.
The exact pathogenesis of the disease is not completely
understood, but it is believed to be the result of a syner-
gistic and multi-bacterial infection, with -hemolytic and
-hemolytic streptococci having the most important
role.24 Clinical presentation can vary, but includes fever,
systemic toxicity, and pain out of proportion to clinical
findings. Diagnosis can be challenging because the dis-
ease does not present with a typical early clinical course.
Diagnosis is best made after surgical debridement has
already been performed. Delays in diagnosis result in
poor clinical outcomes with a mortality rate of 30% to
50%.25 In addition to the loss of function and life incurred
by this condition, the financial healthcare cost could be
deleterious indicating the great importance of best efforts
in avoiding it.
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CASE REPORTAll reports emphasize the importance of early diagnosis
and radical surgical debridement, followed by administra-
tion of broad-spectrum antibiotic agents and intensive
care with aggressive fluid replacement. Hyperbaric oxy-
gen (HBO) may be important as an adjunctive measure in
the treatment of necrotizing fasciitis. The combination of
early, radical debridement and early administration of
HBO has reduced the mortality rate.26,27
Historically, necrotizing fasciitis was first mentioned by
Hippocrates around the fifth century AD as a complication
of erysipelas. In 1871, Joseph Jones provided the first
description of the disease, which he encountered as a
necrotizing soft-tissue infection of the extremities afflict-
ing members of the confederate army during the Civil
War. Meleney28 published a comprehensive report de-
scribing 20 cases of hemolytic Streptococcus gangrene
characterized by rapid onset irregular, indistinct erythema,
blisters, and bullae. In 1918, Pfanner29 described a similar
entity as “necrotizing erysipelas,” attributing it to -hemo-
lytic streptococci. In 1952, Wilson30 published an article
on the entity, which coined the term necrotizing fasciitis.
CVH results in a long surgical wound over the extremity.
Infections are usually apparent early along the suture line.
MIVH harvests the saphenous vein through several small
incisions. This results in a closed space where infection
may not be so apparent initially. We report a case of
necrotizing fasciitis of the lower limb in a patient follow-
ing harvesting of the patient’s saphenous vein for use in a
coronary artery bypass graft.
CASE REPORT
A 47-year-old man, who underwent an off pump, 4-vessel,
coronary artery bypass graft, presented 3 weeks postop-
eratively with right lower leg pain, swelling, and redness
associated with a low-grade fever but no fluctuance. He
Table 1.
Review of Randomized Controlled Trials Comparing Leg Wound Infection Rates After Minimally Invasive and Open Saphenous Vein
Harvesting for Coronary Artery Bypass Grafting
Authors Date MIVH/CVH
a Conversion Follow-up (Days) Leg Infection %
MIVH
a CVH
a
Dusterhoft et al
5 2001 128/127 Not recorded 14 Postdischarge 3.2 9.4
Hayward et al
6 1999 50/50 22% 42 Postdischarge 10 12
Fabricius et al
7 2000 62/30 5% 3 & 6 Postop 3.2 30
Folliguet et al
8 1998 30/30 Not recorded 7 & 10 Postop 3.3 3.3
Puskas et al
9 1999 47/50 6% 28 Postop 4.2 4
Carpino et al
10 2000 66/66 10.6% 14 Postdischarge 4.5 19.7
Tevaerai et al
11 1997 15/15 Not recorded 7 Postop 0 13.3
Allen et al
12 1998 54/58 5.6% 42 Postop 1.9 10.3
Kiaii et al
13 2002 69/65 Not recorded 42 Postop 4.1 22.2
Black et al
14 2002 22/18 18% 42 Postop 4.5 27.8
Cisowski et al
15 2000 45/15 Not recorded 7 Postop 66.6 26.6
Bonde et al
16 2004 30/30 6% 42 Postop 0 13.3
Schurr et al
17 2002 80/60 6% 5 Postop 0 13.3
Isgro et al
18 1999 103/105 2% Not recorded 1.9 8.6
Perrault et al
19 2004 17/15 Not recorded Not recorded 0 6
Wang et al
20 2005 106/119 Not recorded 42 Postop 20.8 41.2
Yun et al
21 2005 100/100 3% 30 Postop 7.4 19.4
Lai et al
22 2006 588/985 Not recorded Not recorded 0.5 2.74
Andreasen et al
23 2008 66/63 14% 30 Postop 3 27
aMIVHminimally invasive vein harvesting; CVHconventional (open) vein harvesting.
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tive heart failure, coronary artery disease, myocardial in-
farction, type II diabetes mellitus, hypertension, and hy-
percholesterolemia. The patient is a chronic heavy smoker
of 3 packs to 4 packs per day for 25 years.
He was initially treated for symptoms and discharged
home on a second-generation cephalosporin. The patient
returned 8 days later, having completed the antibiotic
course, complaining of significant worsening of symp-
toms though he had no fever or chills. On physical exam-
ination, there was a marked increase in tenderness and
erythema, warmth, swelling of his right leg; purulent
drainage was expelled from the endoscopic incision, and
a small distal eschar. The patient was found to have
hyperkalemia; ACE inhibitors and Aldactone were
stopped. There was no leucocytosis. Duplex scan re-
vealed superficial thrombophlebitis. Drainage of the
wound was done at this point, and this was repeated on a
few day intervals after that. Because the patient was afe-
brile with the absence of leucocytosis, this was felt to be
an adequate initial treatment accompanied by intravenous
antibiotics. With no acceptable improvement in wound
healing, the decision was made for radical surgical de-
bridement.
When seen for consultation by the plastic surgery service,
the patient had developed significant additional skin ne-
crosis and erythema (Figure 1), though the patient was
still afebrile without leucocytosis. Upon exploration of the
wound, extensive necrosis was seen subcutaneously lead-
ing to immediate suspicion of necrotizing fasciitis. Radical
debridement was performed. Gram staining of tissue ex-
udates was positive for few polymorph nuclear cells,
many gram-negative rods, while wound culture showed
many Hafnia alvei, few Enterococcus fevalis, and few
Staphylococcus aureus. The specimen consisted of multi-
ple fragments of necrotic tissue, with foci of necrosis,
showing connective tissue with extensive necrosis and
necro-inflammatory debris, as well as acute osteomyelitis
affecting the small bone fragments (Figure 2).
A second debridement was done 2 days later, creating an
open wound composed of most of the medial aspect of
the right leg surface, after which the patient was begun on
a 2-week course of intravenous antibiotics followed by a
10-day course of oral antibiotics, and the patient was
discharged home on hospital day 14 (Figure 3). Repeated
dressing was done thereafter allowing the wound to gran-
ulate over the next 3 months.
When adequate granulation tissue was achieved, the
wound was once again debrided (Figure 4), and the
entire defect was covered with a split-thickness skin graft
(Figure 5). The skin graft continued to heal until the
wound was covered (Figure 6).
DISCUSSION
The patient in this case displayed necrotizing fasciitis,
following a coronary artery bypass graft harvesting of his
saphenous vein. This patient’s condition was caused by a
polymicrobial infection, with few Staphylococcus aureus,
few Enterococcus fevalis, and many Hafnia alvei. While
Staphylococcus and even Enterococcus have been found
in the literature to contribute to necrotizing fasciitis, there
Figure 1. Initial postoperative presentation of the patient; skin
necrosis surrounded by areas of erythema is noted.
Figure 2. Wound presentation after initial radical debridement
of necrotic and infected tissues.
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significant role in the disease state.
Reports of necrotizing fasciitis following the endoscopic
harvesting of a saphenous vein for a CABG in a sterile
setting are exceedingly rare, with no similar cases being
reported in the literature. It starts with a picture of simple
wound infection, but then spirals to be one of the most
dangerous wound infections with a high incurred cost of
life and a financial burden on the healthcare system.
The average total cost of hospital stay following CABG
with endoscopic MIVH in one institution has been quan-
tified at $38 639 compared to $37 169 following CVH.31
The cost of readmission for wound complications (mainly
leg wound infection) has also been estimated at $171 per
patient.32 Despite this, the cost of MIVH looks to be higher
than the cost for CVH. The cost (total patient charges)
incurred for treatment of necrotizing fasciitis could be
deleterious, being very variable. Depending on the sever-
ity and mode of treatment used, it can be anywhere from
US $1025 to $514 889 with a median of $54 533 and a
mean of $34 887; similar costs have also been reported in
other countries.33,34
A systematic review35 with grade A evidence showed that
the wound infection rate was 3% in endoscopic harvesting
compared to 14% for CVH. The study reviewed 14 studies
Figure 3. Wound presentation after second debridement done 2
days after the initial debridement.
Figure 4. Healthy granulation tissue throughout the wound seen
after 3 weeks of repeated dressings and wound care.
Figure 5. Postoperative view of meshed split thickness graft
used to cover the wound surface.
Figure 6. Final wound outcome after complete take of the graft
with full epithelialization of the skin.
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number of pooled subjects was 1527, of which 801 (52%)
had MIVH and 726 (48%) had CVH. Absolute risk reduc-
tion of 7.2% observed in that study meant that for MIVH,
every 14 patients that undergo the minimally invasive
procedure prevent one patient from having a leg wound
infection. The study suggested that minimally invasive
vein harvesting for CABG results in much lower infection
rates owing to reduced traumatic injury to surrounding
tissues, fewer disturbances to skin vascularity and reduced
extent of skin flap creation. None of the patients included
in that systematic review was reported to have a full-
blown picture of necrotizing fasciitis as described in our
case report. This implies the rarity of the case, yet our
report underpins the fact that it could still happen and that
all measures should be taken to avoid its occurrence.
Many of these patients have multiple medical issues and
may not present with traditional findings of elevated tem-
peratures and leucocytosis. Because of the potential for a
closed space infection, aggressive treatment should be
started when this type of infection is clinically suspected.
CONCLUSION
Despite the fact that endoscopic saphenous vein harvest-
ing is a safe procedure, necrotizing fasciitis is a potential
life-threatening complication of this procedure. One
should be cognizant of the atypical presentation of necro-
tizing fasciitis in high-risk patients. In addition to a high
mortality rate, this infection may lead to a great impact on
the quality of the patient’s life as well as financial costs to
the healthcare system.
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